Decades of History Tell Anything: Biotech Near $50 Set to Soar
A cash-generative biotech near $50 is drawing buyers amid a market shift toward defensible healthcare names. Here’s w...
Knowing when to adjust investments for retirement is crucial. Stay ahead by learning the best times and strategies for optimal financial health.
16,299 articlesA cash-generative biotech near $50 is drawing buyers amid a market shift toward defensible healthcare names. Here’s w...
Nuclear energy has moved from niche to core in many energy plans. This guide breaks down the best nuclear energy stoc...
OpenAI’s growing power needs are drawing attention to a little-known Michigan utility tied to a major data-center dea...
The stock move is sharp, but so is the story behind choice hotels stock down. An investor dumped more than $100 milli...
A sharp 60% drop in CBIZ shares has investors buzzing about risk and value. This guide breaks down why the stock move...
Investors are weighing Micron's AI-driven demand against a volatile memory market. This guide breaks down whether you...
A top AI analyst argues the AI revolution is still in its early stages, with ASML’s hefty backlog and robust Q1 2026 ...
COOs across industries say AI accelerates tasks but often lacks direction, creating a widening gap between promise an...
Intel overcame a tough 12 months to deliver a striking rebound. Analysts say the AI-led strategy and foundry expansio...
Palantir posted 70% revenue growth in Q4 2025, led by US commercial gains and a robust free cash flow outlook. Trader...
ASML stock rose in May as demand for EUV technology and a healthier semiconductor cycle supported the rally. This gui...
Walmart’s John Furner rose from a garden center associate to CEO of Walmart U.S., guiding the retailer through a tech...